EWIC 2020 Conference in Budapest

13/03/2020

The East-West Immunogenetics Conference is one of the most well-known events in East-Central Europe and its purpose is to connect experts from the East-European countries with the Western countries. This tradition was initiated in 2006 in Prague, Czech Republic, and since then its popularity is constantly increasing. This year...

Haplotyping Hungarian Paediatric ALL HLA-class II Genes Using NGS

10/03/2020

Abstract presentation by Omixon’s Medior Bioinformatician, Lívia Lázár from the latest 14th East-West Immunogenetics Conference (Budapest, Hungary). Abstract: As a result of an ongoing effort between multiple Hungarian departments of pediatric haematology, 576 patients’ peripheral blood was collected for meta-analysis between 1990 and 2012. The 576 samples were...

“High Throughput HLA Typing Approaches Using NGS” – Omixon Talk in Moscow

09/03/2020

Join Omixon for our talk at the Registries of Bone Marrow Donors: Today and Tomorrow conference in Moscow, Russia on March 12! The talk will be presented by Nina Lauterbach, PhD, Senior Field Application Scientist at Omixon. Date: Thursday, March 12, 2020 Venue: Center for the Development of Charity...

Holotype HLA v3.0.1 is now CE-IVD certified!

28/02/2020

Omixon is pleased to announce that the latest Holotype HLA protocol version (v3.0.1) has received a CE-IVD certificate that complies with the IVD Directive 98/79/EC allowing commercialization of the new version products as IVD in Europe. The new Holotype HLA v3.0.1 kit includes pre-mixed PCR amplification reagents that reduce...

Interview with the South African National Blood Service

28/02/2020

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. This time Dr. Lavendri Govender and Dr. Ute Jentsch from South-African National Blood Service talk about their experiences and thoughts on technology improvements. We...